Literature DB >> 15110003

An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease.

Kewei Chen1, Eric M Reiman, Gene E Alexander, Daniel Bandy, Rosemary Renaut, William R Crum, Nick C Fox, Martin N Rossor.   

Abstract

This article introduces an automated method for the computation of changes in brain volume from sequential magnetic resonance images (MRIs) using an iterative principal component analysis (IPCA) and demonstrates its ability to characterize whole-brain atrophy rates in patients with Alzheimer's disease (AD). The IPCA considers the voxel intensity pairs from coregistered MRIs and identifies those pairs a sufficiently large distance away from the iteratively determined PCA major axis. Analyses of simulated and real MRI data support the underlying assumption of a linear relationship in paired voxel intensities, identify an outlier distance threshold that optimizes the trade-off between sensitivity and specificity in the detection of small volume changes while accounting for global intensity changes, and demonstrate an ability to detect changes as small as 0.04% of brain volume without confounding effects of between-scan shifts in voxel intensity. In eight patients with probable AD and eight age-matched normal control subjects, the IPCA was comparable to the established but partly manual digital subtraction (DS) method in characterizing annual rates of whole-brain atrophy: resulting rates were correlated (Spearman rank correlation = 0.94, P < 0.0005) and comparable in distinguishing probable AD from normal aging (IPCA-detected atrophy rates: 2.17 +/- 0.52% per year in the patients vs. 0.41 +/- 0.22% per year in the controls [Wilcoxon-Mann-Whitney test P = 7.8 x 10(-4)]; DS-detected atrophy rates: 3.51 +/- 1.31% per year in the patients vs. 0.48 +/- 0.29% per year in the controls [P = 7.8 x 10(-4)]). The IPCA could be used in tracking the progression of AD, evaluating the disease-modifying effects of putative treatments, and investigating the course of other normal and pathological changes in brain morphology.

Entities:  

Mesh:

Year:  2004        PMID: 15110003     DOI: 10.1016/j.neuroimage.2004.01.002

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  14 in total

1.  Voxel-based assessment of gray and white matter volumes in Alzheimer's disease.

Authors:  Xiaojuan Guo; Zhiqun Wang; Kuncheng Li; Ziyi Li; Zhigang Qi; Zhen Jin; Li Yao; Kewei Chen
Journal:  Neurosci Lett       Date:  2009-10-30       Impact factor: 3.046

2.  Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD response.

Authors:  Thomas W McAllister; Laura A Flashman; Brenna C McDonald; Richard B Ferrell; Tor D Tosteson; Norman N Yanofsky; Margaret R Grove; Andrew J Saykin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

3.  Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response.

Authors:  Thomas W McAllister; Brenna C McDonald; Laura A Flashman; Richard B Ferrell; Tor D Tosteson; Norman N Yanofsky; Margaret R Grove; Andrew J Saykin
Journal:  Int J Psychophysiol       Date:  2011-07-19       Impact factor: 2.997

4.  Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease.

Authors:  Chengjie Xiong; Hua Weng; David A Bennett; Patricia A Boyle; Raj C Shah; Scot Fague; Charles B Hall; Richard B Lipton; John C Morris
Journal:  Neuroepidemiology       Date:  2014-11-05       Impact factor: 3.282

Review 5.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 6.  Magnetic resonance imaging of Alzheimer's disease.

Authors:  Stéphane Lehéricy; Malgorzata Marjanska; Lilia Mesrob; Marie Sarazin; Serge Kinkingnehun
Journal:  Eur Radiol       Date:  2006-07-25       Impact factor: 5.315

7.  Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.

Authors:  Shichun Peng; Yilong Ma; Phoebe G Spetsieris; Paul Mattis; Andrew Feigin; Vijay Dhawan; David Eidelberg
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

8.  Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease.

Authors:  Chengjie Xiong; Gerald van Belle; Kewei Chen; Lili Tian; Jingqin Luo; Feng Gao; Yan Yan; Ling Chen; John C Morris; Paul Crane
Journal:  Stat Biopharm Res       Date:  2013-01-01       Impact factor: 1.452

9.  A framework for detecting glaucomatous progression in the optic nerve head of an eye using proper orthogonal decomposition.

Authors:  Madhusudhanan Balasubramanian; Stanislav Zabić; Christopher Bowd; Hilary W Thompson; Peter Wolenski; S Sitharama Iyengar; Bijaya B Karki; Linda M Zangwill
Journal:  IEEE Trans Inf Technol Biomed       Date:  2009-04-14

10.  Regional brain morphometry predicts memory rehabilitation outcome after traumatic brain injury.

Authors:  Gary E Strangman; Therese M O'Neil-Pirozzi; Christina Supelana; Richard Goldstein; Douglas I Katz; Mel B Glenn
Journal:  Front Hum Neurosci       Date:  2010-10-14       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.